Attendee Breakdown

This summit is built for the people who are pushing ALS research forward every day. Connect with peers across biotech, pharma, academia and clinical practice to share insights, compare experience, and build the partnerships that accelerate meaningful progress for patients.

Explore the full breakdown and see who’s in the room.

Companies in Attendance

NEW! Alnylam Pharmaceuticals • PTC Therapeutics • Trillium Medical Ventures • University of Toronto

AbbVie • AskBio • Athira Pharma • AviadoBio • Beacon • Biogen • Bristol Myers Squibb • Coya Therapeutics • ROME Therapeutics • Eli Lilly & Co. • EverythingALS • Evestia Clinical • Insmed • ISOgenix Limited • JNJ • Johns Hopkins University • LeonaBio • Neurizon • Neuvivo • NIH • Northwestern University • Novartis AG • Origami Therapeutics, Inc. • Otsuka • PATH • Prilenia Therapeutics • QurAlis • RA Capital Management • Repeat Therapeutics • Sanofi • SK Biopharmaceuticals • Takeda Pharmaceutical • Tanabe Pharma • Trace Neuroscience • Treventis Corp • 2N Pharma • UMC Utrecht • uniQure

Job Titles Represented

Associate • Associate Director • Chief Executive Officer • Chief Medical Officer • Chief Operating Officer • Chief Scientific Officer • Clinical Development Head • Director • Director, Neuroscience • Distinguished Scientist • Executive Director • Founder • Global Head of Medical Affairs • Global Head of Neuroscience • Head of S&E and Invest • Managing Director • Neurologist • Owner • Postdoctoral Fellow • Principal Scientist • Professor & Director • Professor of Pathology & Neuroscience • Research Assistant Professor • Researcher • Scientific Director • Scientific Director, Rare Neurology • Senior Director • Senior Medical Director Clinical Development • Senior Scientist • Senior Vice President, Program Management & Clinical Operations • Staff Scientist • Vice President

Attendee Breakdown Graph
5th ALS Drug Development Event Image (3)
Explore the Agenda

Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 30+ expert speakers shaping the future of ALS & FTD

5th ALS Drug Development Event Image (7)
Partner With Us

Showcase your solutions, connect with decision makers, and position your company as the go-to provider in neuromuscular and neurodegenerative research

5th ALS Drug Development Event Image (2)
Join Biopharma Experts

Network with pharma, biotech, diagnostics, academia, consortia, and patient voices driving real-world adoption